Why
We Exist
Pharmaceutical R&D hasn’t meaningfully changed in decades. Teams still rely on slow and conservative stability studies costing them upward of $250,000 per failed study.
Our
Breakthrough
Nuraxs is the first platform that combines AI models and validated lab results, making drug development faster and more reliable. We can predict where the Arrhenius fails and help you create more optimized stability studies.
Our team
We’re a team of scientists who have seen first-hand how inefficient and outdated R&D processes are. From biotech scientists to AI experts, we are unified under the same goal to help improve the R&D process and get products to patients faster.
Umesh Dangat
